Evidence map›Paper›PMID 36082268›Full record

ArticleFrontiers in medicine2022

Risk factors and management of biliary stones after living donor liver transplant and its effect on graft outcome.

Hany Dabbous, Ashraf Elsayed, Manar Salah, Iman Montasser, Mohamed Atef, Mahmoud Elmetenini

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hany DabbousTropical Medicine Department, Ain Shams Center for Organ Transplantation, Ain Shams University, Cairo, Egypt.
Ashraf ElsayedTropical Medicine Department, Ain Shams Center for Organ Transplantation, Ain Shams University, Cairo, Egypt.
Manar SalahTropical Medicine Department, Ain Shams Center for Organ Transplantation, Ain Shams University, Cairo, Egypt.
Iman MontasserTropical Medicine Department, Ain Shams Center for Organ Transplantation, Ain Shams University, Cairo, Egypt.
Mohamed AtefTropical Medicine Department, Ain Shams University, Cairo, Egypt.
Mahmoud ElmeteniniHepatobiliary Surgical Department, Ain Shams Center for Organ Transplantation, Ain Shams University, Cairo, Egypt.
Ain Shams University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bile stones are associated with numerous complications in liver transplant recipients. Endoscopic retrograde cholangiopancreatography (ERCP) has been proven to be safe and highly effective in dealing with most post-transplant biliary complications. Objective: The objective of this study was to identify the possible risk factors for bile stone formation on top of biliary stricture, the effects of stones on graft outcomes, and their management. Methods: This case-control study included 83 patients who underwent living donor liver transplant (LDLT) and suffered from postoperative biliary stricture with or without stones. Patients were divided into two groups. Group 1 ( Results: The frequency of hepatitis C virus (HCV) was significantly higher in group 2 compared to group 1 (71.4% vs. 47.3%, Conclusion: Positive HCV, biliary drain insertion, donor's BMI, and serum cholesterol level were independent risk factors for developing bile stones on top of biliary strictures. Biliary stones were associated with high episodes of acute graft rejection, and they could be successfully managed by the ERCP modality.

Indexed as

biliary strictureERCPgraft outcomesliving donor liver transplantstones

Identifiers

PMID36082268
PMCPMC9445190
OpenAlexW4292834648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.